Lipophilic polynucleotide conjugates

摘要

Disclosed are lipophilic polynucleotide conjugates including polynucleotide-cholesterol conjugates and methods of delivering therapeutic polynucleotides to a mammalian cell or patient in need of treatment using said conjugates. The disclosure further provides methods of synthesizing the lipophilic polynucleotide conjugates. The conjugates are designed to mimic or target cellular miRNAs. The lipophilic moiety, such as cholesterol or cholesterol derivative, is spaced from the polynucleotide by a substantially linear hydrocarbon group. Due to an absence of significantly polar groups and/or exchangeable protons in the vicinity of the lipophilic moiety, the interaction between the lipophilic moiety and cell membranes is enhanced to provide for efficient entry into cells.

主权项

1. A lipophilic polynucleotide conjugate, comprising:
a) a polynucleotide; and b) a lipophilic moiety selected from cholesterol, cholestene, cholestane, cholestadiene, bile acid, cholic acid, deoxycholic acid, or dehydrocholic acid, wherein the lipophilic moiety is spaced from the polynucleotide and any polar groups or exchangeable protons by a C4 to C10 hydrocarbon linker that is conjugated to the lipophilic moiety through an ether or thioether linkage, wherein the hydrocarbon linker separates any polar groups or exchangeable protons from the lipophilic moiety by at least 6 atoms, and wherein the hydrocarbon linker is conjugated to the polynucleotide through the polynucleotide 3′ position.